MSN LABORATORIES PRIVATE LTD FDA Approval ANDA 214367

ANDA 214367

MSN LABORATORIES PRIVATE LTD

FDA Drug Application

Application #214367

Documents

Letter2021-05-07

Application Sponsors

ANDA 214367MSN LABORATORIES PRIVATE LTD

Marketing Status

None (Tentative Approval)001
None (Tentative Approval)002
None (Tentative Approval)003
None (Tentative Approval)004
None (Tentative Approval)005
None (Tentative Approval)006
None (Tentative Approval)007
None (Tentative Approval)008

Application Products

001UNKNOWNUNKNOWN0SELEXIPAGSELEXIPAG
002TABLET;ORAL0.4MG0SELEXIPAGSELEXIPAG
003TABLET;ORAL0.6MG0SELEXIPAGSELEXIPAG
004TABLET;ORAL0.8MG0SELEXIPAGSELEXIPAG
005TABLET;ORAL1MG0SELEXIPAGSELEXIPAG
006TABLET;ORAL1.2MG0SELEXIPAGSELEXIPAG
007TABLET;ORAL1.4MG0SELEXIPAGSELEXIPAG
008TABLET;ORAL1.6MG0SELEXIPAGSELEXIPAG

FDA Submissions

UNKNOWN; ORIG1TA2021-04-07STANDARD

Submissions Property Types

ORIG1Null31

CDER Filings

MSN LABORATORIES PRIVATE LTD
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 214367
            [companyName] => MSN LABORATORIES PRIVATE LTD
            [docInserts] => ["",""]
            [products] => [{"drugName":"SELEXIPAG","activeIngredients":"SELEXIPAG","strength":"UNKNOWN","dosageForm":"UNKNOWN","marketingStatus":"None (Tentative Approval)","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"04\/07\/2021","submission":"ORIG-1","actionType":"Tentative Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2021-04-07
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.